Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02276534 · ClinicalTrials.gov registry record · NA
SENSE Theatre Intervention for Children With Autism Spectrum Disorder (ASD)
A NA study of Autism Spectrum Disorder, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
- 1
- Study location
NCT02276534: Completed NA study of Autism Spectrum Disorder, sponsored by Vanderbilt University.
NCT02276534 is a NA study of Autism Spectrum Disorder that has completed, run by Vanderbilt University. The registered enrollment target is 136 participants, roughly in line with the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02276534, a NA study of Autism Spectrum Disorder, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigator's goal is to address the need for the development of social interventions for youth with autism in an innovative intervention, SENSE Theatre. The intervention blends established behavioral strategies with theatre techniques that emphasize the involvement of peers, play and performance. The resulting synergy extends promising pilot studies in a randomized group experiment.
Primary Outcome
The measure requires the child to observe 16 faces of children and then remember them immediately and following a 30-minute delay. Raw scores are generated which are converted to standardized scores based on normative data.
Conditions Studied
Interventions
- BEHAVIORAL Delayed Intervention
- BEHAVIORAL SENSE Theatre
Study Locations (1)
Tennessee
- Vanderbilt Kennedy Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-05 |
| Phase | NA |
What the finished NCT02276534 record still lists
NCT02276534 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target.
The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Delayed Intervention is the first listed.
NCT02276534 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT02276534 about?
NCT02276534 is a clinical study titled "SENSE Theatre Intervention for Children With Autism Spectrum Disorder (ASD)". The investigator's goal is to address the need for the development of social interventions for youth with autism in an innovative intervention, SENSE Theatre. The intervention blends established behavioral strategies with theatre techniques that emphasize the involvement of peers, play and performan...
What is the current status of trial NCT02276534?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2014-08. Estimated completion is 2017-05.
What conditions does trial NCT02276534 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder.
What interventions are being tested in trial NCT02276534?
The interventions under investigation include: Delayed Intervention (BEHAVIORAL), SENSE Theatre (BEHAVIORAL).
Who is sponsoring clinical trial NCT02276534?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02276534 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02276534's enrollment target sits among peer trials
136 63rd of 224 higher than 162 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia